Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 13, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
89bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 9
| |||||||
89bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Kala Pharmaceuticals, Inc.
| 20K |
—
|
—
| +100.00% | 40K |
Jun 17
| |||||||
89bio, Inc.
| -850.00 |
$27.60 | -$23,460.00 | -100.00% |
0
|
Apr 21
| |||||||
89bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 15
| |||||||
89bio, Inc.
| -849.15K |
—
|
—
| -32.65% | 1.75M |
Nov 16
| |||||||
89bio, Inc.
| 109.09K |
$27.50 | $2,999,975.00 | +4.38% | 2.6M |
Jul 10
| |||||||
89bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Kala Pharmaceuticals, Inc.
| 20K |
—
|
—
|
∞
| 20K |
Jun 25
| |||||||
89bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 5
| |||||||
Kala Pharmaceuticals, Inc.
| 2.53M |
$7.89 | $19,999,998.06 |
∞
| 2.53M |
Mar 13
| |||||||
89bio, Inc.
| 2.49M |
$16.00 |
—
|
∞
| 2.49M |
Nov 11 - Nov 13
| |||||||
89bio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Kala Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 5
| |||||||
Kala Pharmaceuticals, Inc.
| 606.06K |
$8.25 | $4,999,995.00 | +26.69% | 2.88M |
Oct 5
| |||||||
Kala Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 12
| |||||||
Kala Pharmaceuticals, Inc.
| 2.27M |
$15.00 |
—
|
∞
| 2.27M |
Jul 25
| |||||||
Kala Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 19
| |||||||
Kala Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||